PHILADELPHIA (AP) — Novel drugs may offer fresh ways to reduce heart risks beyond the usual medicines to lower cholesterol and blood pressure.
WASHINGTON (AP) — Some good health news: Americans' cholesterol levels are dropping, and more people at especially high risk are getting treatment.
A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat...
LONDON (AP) — A cheap daily pill that combines four drugs cut the risk of heart attacks, strokes and heart failure in a large study, suggesting it could be a good way to help prevent heart...
CHICAGO (AP) — Cholesterol levels in children and teens improved in the latest analysis of U.S. health surveys, yet only half of them had readings considered ideal.
The latest U.S. research on eggs won't go over easy for those who can't eat breakfast without them.
Adults who ate about 1 ½ eggs daily had a slightly higher risk of heart disease than those...
WASHINGTON (AP) — President Donald Trump has put on some pounds and is now officially considered obese.
The White House on Thursday released results of his most recent physical, revealing that his Body Mass Index is now 30.4. That's based on the fact that he's now carrying 243 pounds on his 6-foot, 3-inch frame. That's up from 236 pounds in September 2016 before he became president.
Doctors revise heart attack prevention guidelines
CHICAGO (AP) — Fish oil, vitamin D, novel drugs, new cholesterol guidelines: News from an American Heart Association conference over the weekend reveals a lot about what works and what does not for preventing heart attacks and other problems.
Dietary supplements missed the mark, but a prescription-strength fish oil showed promise. A drug not only helped people with diabetes control blood sugar and lose weight, but also lowered their risk of needing hospitalization for heart failure.
TRENTON, N.J. (AP) — The maker of an expensive cholesterol drug is slashing the list price, which should make it more affordable for patients.
Amgen Inc. said Wednesday it is immediately cutting the price of Repatha by 60 percent, from about $14,000 to $5,850 per year.
RENO, Nev. (AP) — Jordan Stiteler joined thousands of other Nevada residents in a DNA testing program known as the Healthy Nevada Project to verify her Swedish ancestry.
But the 29-year-old Reno resident instead found out how important genetic testing can be in catching potentially big health problems early, the Reno Gazette-Journal reported earlier this month.
WASHINGTON (AP) — You know your cholesterol, your blood pressure ... your heart gene score? Researchers say a new way of analyzing genetic test data may one day help identify people at high risk of a youthful heart attack in time to help.
ORLANDO, Fla. (AP) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often.
Results on the drug, Praluent (PRALL-yoo-ent), were announced Saturday at an American College of Cardiology conference in Florida. It's the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago.
TRENTON, N.J. (AP) — Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results.
Merck's decision Wednesday to not seek regulatory approval after years of testing marks the fourth time this type of once-promising drug has been scrapped. Merck had continued to study its drug, a so-called CETP inhibitor called anacetrapib, long after rivals had given up on similar drugs.
BOSTON (AP) — A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a cholesterol medication.
The U.S. attorney's office in Boston said Friday that Aegerion Pharmaceuticals has agreed to plead guilty to two misdemeanor counts of violating federal law when it sold and promoted the drug Juxtapid as a general treatment for high cholesterol.
TRENTON, N.J. (AP) — So-so results for a new type of cholesterol drug have left Merck in a quandary: Does the company try to bring it to market or scrap it?
A large, long-term study of the drug showed that it prevents heart attacks and reduces the need for heart procedures, while three similar drugs developed by rivals failed. But the drug, anacetrapib, only reduced those complications by 9 percent.
For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.
People on the drug also had surprisingly lower cancer death rates, especially from lung cancer. An anti-tumor effect is an exciting possibility, but it needs much more study because the heart experiment wasn't intended to test that.
TRENTON, N.J. (AP) — Merck & Co. said Tuesday that a new type of cholesterol drug reduced heart attacks, deaths and other complications of heart disease in a huge, late-stage study.
The positive result was a welcome surprise because three previous experimental drugs of the same type had failed.
VATICAN CITY (AP) — Pope Francis is trying to energize Catholics, telling them to be active, help others, spread the faith, and that's all good for cholesterol levels, too.
Francis himself looked full of pep Sunday, a day after the 80-year-pontiff returned from a hectic trip to Egypt.
In St. Peter's Square, he did a whirl in his popemobile to greet some 70,000 members and supporters of Italian Catholic Action, a social-action group celebrating 150 years since its formation.
A long-acting cholesterol medicine cut the risk of having a heart attack or some other serious problems by 15 to 20 percent in a big study that's likely to spur fresh debate about what drugs should cost.
Statins such as Lipitor and Crestor are cheap and lower LDL or bad cholesterol, but some people can't tolerate or get enough help from them. The new drug, Amgen's Repatha, is given as a shot once or twice a month and is part of a novel class of medicines that drop LDL to unprecedented levels.
NEW ORLEANS (AP) — For the first time, a new drug given along with a cholesterol-lowering statin medicine has proved able to shrink plaque that is clogging arteries, potentially giving a way to undo some of the damage of heart disease.
The difference was very small but doctors hope it will grow with longer treatment, and any reversal or stabilization of disease would be a win for patients and a long-sought goal.
Drugmaker Pfizer topped off a difficult third quarter with news that it's scrapping a closely watched experimental cholesterol drug, partly due to expectations insurers would limit access so much that it wouldn't make much money, a possible bad omen for the pharmaceutical industry.
What if a blood test could reveal that your child is at high risk for early heart disease years in the future, giving you a chance to prevent it now? A big study in England did that — screening thousands of babies for inherited risk — and found it was twice as common as has been thought.
The study also revealed parents who had the condition but didn't know it, and had passed it on to their children. Ninety percent of them started taking preventive medicines after finding out.
WASHINGTON (AP) — Donald Trump released a letter from his doctor on Thursday that showed the Republican presidential candidate takes cholesterol-lowering medication and is overweight, but concludes that overall he is "in excellent physical health."
WHITE PLAINS, N.Y. (AP) — Hillary Clinton returns to the campaign trail Thursday following a bout of pneumonia that sidelined her for three days and revived questions about both the Democratic nominee and Republican Donald Trump's transparency regarding their health.
- Business WireThe Medicines Company Announces Positive Topline Results for ORION-9 Phase 3 Study of Inclisiran in Heterozygous Familial Hypercholesterolemia PatientsSeptember 25, 2019
- NewMediaWireOne daily combo pill helps lower heart disease risk in study of underserved patientsSeptember 18, 2019
- Business WirePositive Results Highlight Potential of Bempedoic Acid / Ezetimibe Combination for Hypercholesterolaemia with Type 2 DiabetesAugust 29, 2019
- Business WireCORRECTING and REPLACING Kowa Pharmaceuticals America, Inc. Receives Pediatric Indication and Six-Month Pediatric Exclusivity for LIVALO® (pitavastatin)June 20, 2019
- BusinessWireGlobal Statin Market (2019-2023) is Forecast to Register a CAGR of Over 2% - ResearchAndMarkets.comDecember 7, 2018